Problem/Issue Statement
- Procter & Gamble’s trial process is very tedious and extensive and results in delayed data locks which could ultimately push back the market entry of a drug.
- The problem that Procter & Gamble faces is the need to improve the current process. The symptoms associated with P&G’s problem are duplication of efforts which could total up to 25 labor hours during the course of a trial. In addition, there is the possibility of human error related to data entry which could result in further delays and errors. P&G’s current process also involves frequent and costly sponsor support.
- The scope of the problem involves the need to improve the overall trial process at Procter & Gamble. It is not solely a data entry issue but must also review the entire process to ensure the flow and data gaps and concerns are addressed as appropriate.
Situation Assessment
- While the most attractive alternative for P&G is the implementation of EDC, P&G must also consider the effect on the overall process. As mentioned before, the issue is not solely a data entry issue which causes delay in the trial process. While this lag or delay may be solved with the EDC, it will be necessary to evaluate the entire process.
List of Plausible Alternative Courses of Action
- The three alternatives that P&G has analyzed as a potential solution to the problem it faces are:
- Improving the paper based process
- Digital imaging
- Web enabled electronic data capture (EDC)
- The alternatives address P&G’s problems as follows:
- Improving the paper based process: This alternative would address the issue at hand by adjusting the paper based system. This alternative would keep everything “status-quo” as far as data collection is concerned. The adjustments that would be implemented would be using express mail shipments and increased staffing to perform site monitoring and data verification. The implement of this alternative would result in faster data verification but would not likely improve the trial process.
- Digital imaging: This alternative would not change the paper based system. By implementing data imaging, P&G would be able to digitally transmit data from investigator sites to the pharmaceutical sponsor. They would be able to transmit the data electronically and store it within the system. This alternative requires an extensive amount of storage in order to be able to store the documents and data related to the various studies.
- Web enabled electronic data capture (EDC): This alternative would completely change the data collection and trial process for P&G. The implementation of the EDC required the re-design of the data collection process. This alternative requires the most work upfront but can potentially favor P&G the most.
Recommendation
After reading the case, I would recommend that P&G implement the EDC to improve their trial process. By implementing EDC, the data would be entered to the data management system directly by the investigative sites. P&G would also be able to establish rules to perform data validation without having to do double data entry. Querying and data validation can be built within the EDC. The EDC would also make data available immediately to the sponsor, whereas, with the current paper based process, the sponsor had to wait longer for the data to be available to them. The EDC would require fewer visits from the sponsors to the sites, hence, providing a cost savings to P&G.
While the implementation of an EDC would potentially reduce the period of time needed to data lock from by half, it is still important to consider the other resources and changes that would be required in order to shift towards the EDC. This alternative would require upfront investment in development and maintenance of all electronic case report forms (eCRFs) and help desk support for clinical sites. Additionally, P&G would have to invest in training and change management to roll out the EDC to ensure sponsors, data entry specialists, and all others involved in the trial process would learn the new process. It may take a longer period of time to adapt to the EDC given potential resistance to change, but in the long run, I would recommend that P&G implement the EDC as it will provide a wider range of benefits which will address the issue at hand which is the need to reduce the length of time it takes to data lock.
~~~~~~~~~~~~~~~~~~~~~~~~~~~
Reflection:
After attending the consultant's presentation and listening to their point of view regarding the alternatives to resolve the issue at hand, I am confident that I agree with the recommendation I initially presented and was confirmed by the consultants. The implementation of the EDC is likely to be a rewarding investment for Procter and Gamble. EDC will enable P&G to be able to reduce the time it takes to data lock and potentially reduce the overall trial process time.
No comments:
Post a Comment